Noriyuki Sasaki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A 3-Year Post-Marketing Surveillance Study of EX-PRESS™ Glaucoma Filtration Device in Japanese Eyes.
A 3-Year Post-Marketing Surveillance Study of EX-PRESS™ Glaucoma Filtration Device in Japanese Eyes.
Journal: Advances in therapy
Published: July 31, 2025
Clinical Results of a Trifocal Toric Intraocular Lens Using the Holladay Total Surgically Induced Astigmatism Formula for Correcting Low Corneal Astigmatism in Japanese Patients.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 09, 2023
Comparison of Femtosecond Laser-Assisted Cataract Surgery and Conventional Phacoemulsification on Endothelial Cell Density When Using Torsional Modality.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: July 31, 2021
One-year multicenter evaluation of a new hydrophobic acrylic intraocular lens with hydroxyethyl methacrylate in an automated preloaded delivery system.
Journal: Journal of cataract and refractive surgery
Published: June 10, 2021
Experimental Study on Delivery Performance of an Automated Preloaded Intraocular Lens Injector System for Corneal and Sclerocorneal Incisions.
Journal: Journal of ophthalmology
Published: February 11, 2021
Results of a clinical evaluation of a trifocal intraocular lens in Japan.
Journal: Japanese journal of ophthalmology
Published: May 07, 2019
Twelve-month efficacy and safety of glaucoma filtration device for surgery in patients with normal-tension glaucoma.
Journal: Japanese journal of ophthalmology
Published: November 06, 2018
Influence of surface light scattering and glistenings of intraocular lenses on visual function 15 to 20 years after surgery.
Journal: Journal of cataract and refractive surgery
Published: October 25, 2017
Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.
Journal: Expert opinion on pharmacotherapy
Published: July 26, 2017
Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients.
Journal: Acta ophthalmologica
Published: October 13, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026